<?xml version="1.0" encoding="utf-8" ?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN"
                  "JATS-publishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.2" article-type="other">
<front>
<journal-meta>
<journal-id></journal-id>
<journal-title-group>
<journal-title>Journal of Open Source Software</journal-title>
<abbrev-journal-title>JOSS</abbrev-journal-title>
</journal-title-group>
<issn publication-format="electronic">2475-9066</issn>
<publisher>
<publisher-name>Open Journals</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">9070</article-id>
<article-id pub-id-type="doi">10.21105/joss.09070</article-id>
<title-group>
<article-title>biodiscvr: Biomarker Discovery Using Composite Value
Ratios</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7612-5331</contrib-id>
<name>
<surname>Llorente-Saguer</surname>
<given-names>Isaac</given-names>
</name>
<xref ref-type="aff" rid="aff-1"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0203-3909</contrib-id>
<name>
<surname>Oxtoby</surname>
<given-names>Neil P.</given-names>
</name>
<xref ref-type="aff" rid="aff-1"/>
<xref ref-type="corresp" rid="cor-1"><sup>*</sup></xref>
</contrib>
<aff id="aff-1">
<institution-wrap>
<institution>UCL Hawkes Institute and Department of Computer Science,
University College London, United Kingdom</institution>
<institution-id institution-id-type="ROR">02jx3x895</institution-id>
</institution-wrap>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor-1">* E-mail: <email></email></corresp>
</author-notes>
<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2025-05-20">
<day>20</day>
<month>5</month>
<year>2025</year>
</pub-date>
<volume>11</volume>
<issue>118</issue>
<fpage>9070</fpage>
<permissions>
<copyright-statement>Authors of papers retain copyright and release the
work under a Creative Commons Attribution 4.0 International License (CC
BY 4.0)</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>The article authors</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Authors of papers retain copyright and release the work under
a Creative Commons Attribution 4.0 International License (CC BY
4.0)</license-p>
</license>
</permissions>
<kwd-group kwd-group-type="author">
<kwd>R</kwd>
<kwd>biomarkers</kwd>
<kwd>neuroimaging</kwd>
<kwd>Alzheimer's disease</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="summary">
  <title>Summary</title>
  <p><bold>biodiscvr</bold> provides a framework for discovering and
  evaluating optimised biomarkers defined as ratios of composite values
  derived from feature sets (e.g., regional measurements from imaging
  data). The conceptual approach is domain‚Äëagnostic, but the current
  implementation is tailored to Alzheimer‚Äôs disease (AD) research,
  reflecting the motivating use cases that guided its development. As
  such, several preprocessing utilities, expected variable names, and
  default assumptions correspond to common AD datasets (e.g., cognitive
  status groupings, amyloid/tau measures, and region‚Äëof‚Äëinterest
  conventions).</p>
  <p>The core functionality utilises a Genetic Algorithm (GA) to search
  the feature space for optimal numerator and denominator combinations
  based on biomarker performance metrics calculated using linear
  mixed‚Äëeffects models (Group Separation, Sample Size Estimates).</p>
  <p>The framework allows users to define inclusion criteria (in
  <monospace>config.yaml</monospace> or overriding workflow functions),
  preprocess data, run the discovery workflow, perform regional ablation
  analyses, and evaluate lists of biomarkers (including those discovered
  by the algorithm) across multiple datasets. Although the current
  release is AD‚Äëfocused, the architecture is designed to support future
  extensions toward more domain‚Äëagnostic workflows.</p>
</sec>
<sec id="statement-of-need">
  <title>Statement of need</title>
  <p>A <bold>composite value ratio (CVR)</bold>
  (<xref alt="Saguer et al., 2022" rid="ref-saguer2022composite" ref-type="bibr">Saguer
  et al., 2022</xref>) is defined as the ratio between two composite
  aggregations of features. This concept is widely used in neuroimaging,
  where shared confounding factors (such as global signal intensity or
  individual variations in tracer pharmacokinetics) can partially cancel
  out when using ratios, thereby revealing more robust biological
  signals. Traditionally, these ratios (e.g., the Standardised Uptake
  Value ratio in PET) are determined based on expert knowledge and
  manual selection of target and reference regions.</p>
  <p>While standard feature selection frameworks (e.g., those
  implementing Lasso or Elastic Net regularisation) are effective for
  identifying individual predictors in linear models, they are not
  designed to explore the combinatorial and symbolic space of feature
  groupings and ratios. Exhaustive search of all possible CVR
  combinations is computationally unfeasible; for a typical neuroimaging
  template with 100 regions (or features), the search space for possible
  ratios exceeds <inline-formula><alternatives>
  <tex-math><![CDATA[10^{46}]]></tex-math>
  <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:msup><mml:mn>10</mml:mn><mml:mn>46</mml:mn></mml:msup></mml:math></alternatives></inline-formula>
  combinations. <monospace>biodiscvr</monospace> addresses this by
  providing an automated exploratory framework to discover
  high-performing CVRs tailored to specific clinical or research
  objectives, such as maximising group separation or minimising sample
  size requirements Llorente-Saguer &amp; Oxtoby
  (<xref alt="2026" rid="ref-llorente2026enhanced" ref-type="bibr">2026</xref>).</p>
  <p>A novel contribution of this implementation is the introduction of
  <bold>multicohort regularisation</bold> (see Methods). Traditionally,
  biomarker discovery is performed on single datasets or pooled data.
  Pooling often requires intensive data harmonisation to mitigate batch
  effects and can lead to models that overfit to the most prevalent data
  structure. <monospace>biodiscvr</monospace> advances the CVR framework
  by treating independent datasets as separate entities during
  optimisation. By calculating a composite fitness (objective metric)
  across these datasets without requiring data merging, the framework
  prioritises biomarkers that perform consistently across diverse
  populations. This approach ensures that the resulting biomarkers are
  not only statistically significant but also robust and
  generalisable.</p>
  <p>The current implementation of biodiscvr leverages several
  established R packages to manage its core components. The GA package
  (<xref alt="Scrucca, 2016" rid="ref-scrucca2016some" ref-type="bibr">Scrucca,
  2016</xref>) serves as the default exploratory engine. While the
  genetic algorithm provides an efficient means of navigating the
  high-dimensional feature space, the framework is designed to be
  modular, allowing for the future integration of alternative
  optimisation strategies. Statistical evaluation is conducted using
  lme4
  (<xref alt="Bates et al., 2015" rid="ref-lme4" ref-type="bibr">Bates
  et al., 2015</xref>), which fits linear mixed-effects models to assess
  the biomarkers, while lmmpower
  (<xref alt="Iddi &amp; Donohue, 2022" rid="ref-longpower" ref-type="bibr">Iddi
  &amp; Donohue, 2022</xref>) calculates the sample size requirements
  for hypothetical clinical trials based on these models.</p>
</sec>
<sec id="software-architecture-and-workflow">
  <title>Software Architecture and Workflow</title>
  <p><monospace>biodiscvr</monospace> is implemented as a modular R
  pipeline designed to handle the logistical and computational
  complexities of multi-cohort biomarker discovery. The framework is
  structured into four functional layers that manage the transition from
  raw data to optimised, parsimonious biomarkers:</p>
  <sec id="configuration-and-parameter-control">
    <title>1. Configuration and Parameter Control</title>
    <p>The workflow is entirely parameter-driven via a central
    <monospace>config.yaml</monospace> file. This file defines the
    search space (feature sets), statistical parameters (power, effect
    size), and Genetic Algorithm (GA) constraints. This decoupling of
    logic from parameters ensures that experiments are reproducible and
    allows the same discovery engine to be applied to different disease
    domains by simply modifying the configuration schema.</p>
  </sec>
  <sec id="data-harmonisation-layer">
    <title>2. Data Harmonisation Layer</title>
    <p>To facilitate multi-cohort analysis without data merging, the
    package provides utilities for automated data preparation. The
    <monospace>load_datasets()</monospace> and
    <monospace>preprocess_data()</monospace> functions use
    dictionary-based matching to resolve naming inconsistencies across
    independent sites (e.g., mapping heterogeneous regional labels to a
    standard template). This layer ensures that the discovery engine
    operates on harmonised data structures while preserving the unique
    statistical properties of each original cohort.</p>
  </sec>
  <sec id="the-discovery-engine">
    <title>3. The Discovery Engine</title>
    <p>The core discovery process is managed by
    <monospace>run_experiments()</monospace>, which manages
    single-cohort or multi-cohort optimisation runs. This function
    interfaces with the <monospace>GA</monospace> package to navigate
    the high-dimensional feature space. In each generation of the
    search, candidate biomarkers are passed to an internal evaluation
    loop that fits linear mixed-effects models (via
    <monospace>lme4</monospace>) and calculates clinical utility metrics
    (via <monospace>lmmpower</monospace>). The multicohort consensus
    logic (see <italic>Methods</italic>) is then applied to aggregate
    these metrics into a single fitness score.</p>
  </sec>
  <sec id="evaluation-and-parsimony-refinement">
    <title>4. Evaluation and Parsimony Refinement</title>
    <p>Beyond the initial discovery, the framework includes tools for
    post-hoc validation and refinement. The
    <monospace>run_ablation()</monospace> function performs a systematic
    ‚Äúfeature removal‚Äù analysis on discovered biomarkers. This process
    identifies the marginal contribution of each region to the overall
    fitness, allowing the user to simplify complex feature sets into
    more parsimonious biomarkers without a significant loss in
    statistical power. Finally,
    <monospace>evaluate_biomarkers()</monospace> allows for the
    standardised testing of these results across independent ‚Äúhold-out‚Äù
    datasets to confirm generalisability.</p>
  </sec>
</sec>
<sec id="methods">
  <title>Methods</title>
  <p>The core of <monospace>biodiscvr</monospace> is a heuristic search
  for an optimal feature set (biomarker) that minimises an objective
  function across <inline-formula><alternatives>
  <tex-math><![CDATA[K]]></tex-math>
  <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>K</mml:mi></mml:math></alternatives></inline-formula>
  independent cohorts. The framework treats biomarker discovery as a
  multi-objective optimisation problem and transforms it into a
  single-objective search via a consensus fitness function.</p>
  <sec id="individual-cohort-metrics">
    <title>Individual Cohort Metrics</title>
    <p>For each cohort <inline-formula><alternatives>
    <tex-math><![CDATA[i]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>i</mml:mi></mml:math></alternatives></inline-formula>,
    the framework fits a linear mixed-effects model to the
    log-transformed candidate biomarker
    (<xref alt="Saguer et al., 2022" rid="ref-saguer2022composite" ref-type="bibr">Saguer
    et al., 2022</xref>). The discovery process is guided by two primary
    statistical metrics:</p>
    <list list-type="order">
      <list-item>
        <p><bold>Sample Size (<inline-formula><alternatives>
        <tex-math><![CDATA[N]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>N</mml:mi></mml:math></alternatives></inline-formula>):</bold>
        The estimated <inline-formula><alternatives>
        <tex-math><![CDATA[N]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>N</mml:mi></mml:math></alternatives></inline-formula>
        required for a hypothetical clinical trial to detect a
        predefined change. Parameters (e.g., 80% power, 20% effect size)
        are defined in the <monospace>config.yaml</monospace> file.</p>
      </list-item>
      <list-item>
        <p><bold>Group Separation (<inline-formula><alternatives>
        <tex-math><![CDATA[t]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>t</mml:mi></mml:math></alternatives></inline-formula>):</bold>
        The <inline-formula><alternatives>
        <tex-math><![CDATA[t]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>t</mml:mi></mml:math></alternatives></inline-formula>-statistic
        associated with the fixed effect of a binary group (e.g.,
        amyloid status).</p>
      </list-item>
    </list>
    <p>These are combined into a scalar fitness value
    <inline-formula><alternatives>
    <tex-math><![CDATA[f_i = t/N]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>t</mml:mi><mml:mi>/</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>.
    To avoid a state where the algorithm cannot improve sample size
    without sacrificing group separation (Pareto frontier), the
    <inline-formula><alternatives>
    <tex-math><![CDATA[t]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>t</mml:mi></mml:math></alternatives></inline-formula>-statistic
    is truncated at a saturation point (defaulting to 2.6, or
    <inline-formula><alternatives>
    <tex-math><![CDATA[p \approx 0.005]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>p</mml:mi><mml:mo>‚âà</mml:mo><mml:mn>0.005</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>).
    This allows the optimiser to prioritise the reduction of
    <inline-formula><alternatives>
    <tex-math><![CDATA[N]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>N</mml:mi></mml:math></alternatives></inline-formula>
    once a sufficient threshold of statistical significance is
    reached.</p>
  </sec>
  <sec id="multicohort-regularisation">
    <title>Multicohort Regularisation</title>
    <p>To identify biomarkers that generalise across populations without
    merging datasets (thus avoiding batch effects),
    <monospace>biodiscvr</monospace> treats the fitness scores from
    <inline-formula><alternatives>
    <tex-math><![CDATA[K]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>K</mml:mi></mml:math></alternatives></inline-formula>
    cohorts as a vector <inline-formula><alternatives>
    <tex-math><![CDATA[\mathbf{F} = [f_1, f_2, \dots, f_K]]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>ùêÖ</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false" form="prefix">[</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mi>‚Ä¶</mml:mi><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>K</mml:mi></mml:msub><mml:mo stretchy="false" form="postfix">]</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>.
    The global fitness <inline-formula><alternatives>
    <tex-math><![CDATA[G]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>G</mml:mi></mml:math></alternatives></inline-formula>
    is calculated using the product of absolute individual fitnesses, an
    angular penalty, and a directional sign:</p>
    <p><disp-formula><alternatives>
    <tex-math><![CDATA[G = s \cdot \left( \prod_{i=1}^{K} |f_i| \right) \cdot \cos^2(\theta)]]></tex-math>
    <mml:math display="block" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>G</mml:mi><mml:mo>=</mml:mo><mml:mi>s</mml:mi><mml:mo>‚ãÖ</mml:mo><mml:mrow><mml:mo stretchy="true" form="prefix">(</mml:mo><mml:munderover><mml:mo>‚àè</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>K</mml:mi></mml:munderover><mml:mo stretchy="false" form="prefix">|</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false" form="prefix">|</mml:mo><mml:mo stretchy="true" form="postfix">)</mml:mo></mml:mrow><mml:mo>‚ãÖ</mml:mo><mml:msup><mml:mi>cos</mml:mi><mml:mo>&#8289;</mml:mo><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false" form="prefix">(</mml:mo><mml:mi>Œ∏</mml:mi><mml:mo stretchy="false" form="postfix">)</mml:mo></mml:mrow></mml:math></alternatives></disp-formula></p>
    <p>Where <inline-formula><alternatives>
    <tex-math><![CDATA[\theta]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>Œ∏</mml:mi></mml:math></alternatives></inline-formula>
    (<xref alt="Llorente-Saguer et al., 2025" rid="ref-llorente2025theta" ref-type="bibr">Llorente-Saguer
    et al., 2025</xref>) is the angle between the fitness vector
    <inline-formula><alternatives>
    <tex-math><![CDATA[\mathbf{F}]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>ùêÖ</mml:mi></mml:math></alternatives></inline-formula>
    and a <bold>reference direction vector</bold>
    <inline-formula><alternatives>
    <tex-math><![CDATA[\mathbf{R}]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>ùêë</mml:mi></mml:math></alternatives></inline-formula>,
    and <inline-formula><alternatives>
    <tex-math><![CDATA[s]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>s</mml:mi></mml:math></alternatives></inline-formula>
    represents the directional consistency.</p>
    <list list-type="bullet">
      <list-item>
        <p><bold>Product-based Aggregation:</bold> By using the product
        of fitnesses rather than the sum, the framework ensures that a
        biomarker must perform well across <italic>all</italic> cohorts.
        A low performance in any single cohort will heavily penalise the
        global score.</p>
      </list-item>
      <list-item>
        <p><bold>Reference Direction (<inline-formula><alternatives>
        <tex-math><![CDATA[\mathbf{R}]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>ùêë</mml:mi></mml:math></alternatives></inline-formula>):</bold>
        This vector represents the desired balance of performance across
        cohorts. While it can be a vector of ones
        <inline-formula><alternatives>
        <tex-math><![CDATA[[1, 1, \dots, 1]]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mo stretchy="false" form="prefix">[</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>‚Ä¶</mml:mi><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false" form="postfix">]</mml:mo></mml:mrow></mml:math></alternatives></inline-formula>,
        the framework defaults to the single best performance achieved
        per cohort, defining an adaptable performance ceiling.</p>
      </list-item>
      <list-item>
        <p><bold>Angular Penalty (<inline-formula><alternatives>
        <tex-math><![CDATA[\cos^2\theta]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msup><mml:mi>cos</mml:mi><mml:mo>&#8289;</mml:mo><mml:mn>2</mml:mn></mml:msup><mml:mi>Œ∏</mml:mi></mml:mrow></mml:math></alternatives></inline-formula>):</bold>
        This term penalises candidate biomarkers with high angular
        deviation from the reference, effectively enforcing consensus
        across cohorts (i.e., avoiding overfitting to a subset of
        cohorts).</p>
      </list-item>
      <list-item>
        <p><bold>Directional Sign (<inline-formula><alternatives>
        <tex-math><![CDATA[s]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>s</mml:mi></mml:math></alternatives></inline-formula>):</bold>
        To ensure biological validity, <inline-formula><alternatives>
        <tex-math><![CDATA[s]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>s</mml:mi></mml:math></alternatives></inline-formula>
        is set to <inline-formula><alternatives>
        <tex-math><![CDATA[1]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mn>1</mml:mn></mml:math></alternatives></inline-formula>
        only if all individual cohort fitnesses
        <inline-formula><alternatives>
        <tex-math><![CDATA[f_i]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math></alternatives></inline-formula>
        are positive. If any <inline-formula><alternatives>
        <tex-math><![CDATA[f_i < 0]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&lt;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>
        (indicating a reversed effect direction),
        <inline-formula><alternatives>
        <tex-math><![CDATA[s]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>s</mml:mi></mml:math></alternatives></inline-formula>
        is set to <inline-formula><alternatives>
        <tex-math><![CDATA[-1]]></tex-math>
        <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mrow><mml:mi>‚àí</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:math></alternatives></inline-formula>.</p>
      </list-item>
    </list>
  </sec>
  <sec id="optimisation-strategy">
    <title>Optimisation Strategy</title>
    <p>The framework navigates the combinatorial space of feature ratios
    and groupings using an exploratory search algorithm, currently
    implemented via a Genetic Algorithm. The use of the directional sign
    <inline-formula><alternatives>
    <tex-math><![CDATA[s]]></tex-math>
    <mml:math display="inline" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>s</mml:mi></mml:math></alternatives></inline-formula>
    creates a ‚Äúhard barrier‚Äù in the search space, guiding the algorithm
    away from invalid solutions. This approach enables the discovery of
    complex, multi-feature biomarkers that are robust across
    heterogeneous datasets and would be computationally intractable to
    identify via exhaustive search.</p>
  </sec>
</sec>
<sec id="citations">
  <title>Citations</title>
  <p>This package builds upon the methodologies described in
  (<xref alt="Llorente-Saguer &amp; Oxtoby, 2024" rid="ref-llorente2024" ref-type="bibr">Llorente-Saguer
  &amp; Oxtoby, 2024</xref>), and later expanded on
  (<xref alt="Llorente-Saguer &amp; Oxtoby, 2026" rid="ref-llorente2026enhanced" ref-type="bibr">Llorente-Saguer
  &amp; Oxtoby, 2026</xref>). The multicohort analysis has been possible
  thanks to theta
  (<xref alt="Llorente-Saguer et al., 2025" rid="ref-llorente2025theta" ref-type="bibr">Llorente-Saguer
  et al., 2025</xref>), a summary metric involving multiple
  dimensions.</p>
</sec>
<sec id="acknowledgements">
  <title>Acknowledgements</title>
  <p>Thank you, David P√©rez Su√°rez, for testing the package and
  providing feedback. We acknowledge funding from a UKRI Future Leaders
  Fellowship (MR/S03546X/1, MR/X024288/1).</p>
  <p>The current implementation relies on the following R packages: (GA
  (<xref alt="Scrucca, 2016" rid="ref-scrucca2016some" ref-type="bibr">Scrucca,
  2016</xref>), lme4
  (<xref alt="Bates et al., 2015" rid="ref-lme4" ref-type="bibr">Bates
  et al., 2015</xref>), lmmpower
  (<xref alt="Iddi &amp; Donohue, 2022" rid="ref-longpower" ref-type="bibr">Iddi
  &amp; Donohue, 2022</xref>)).</p>
</sec>
</body>
<back>
<ref-list>
  <title></title>
  <ref id="ref-llorente2024">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Llorente-Saguer</surname><given-names>Isaac</given-names></name>
        <name><surname>Oxtoby</surname><given-names>Neil P</given-names></name>
      </person-group>
      <article-title>A data-driven framework for biomarker discovery applied to optimizing modern clinical and preclinical trials on alzheimer‚Äôs disease</article-title>
      <source>Brain Communications</source>
      <publisher-name>Oxford University Press UK</publisher-name>
      <year iso-8601-date="2024">2024</year>
      <volume>6</volume>
      <issue>6</issue>
      <pub-id pub-id-type="doi">10.1093/braincomms/fcae438</pub-id>
      <fpage>fcae438</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-saguer2022composite">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Saguer</surname><given-names>Isaac Llorente</given-names></name>
        <name><surname>Busche</surname><given-names>Marc A</given-names></name>
        <name><surname>Oxtoby</surname><given-names>Neil P</given-names></name>
      </person-group>
      <article-title>Composite SUVR: A new method for boosting alzheimer‚Äôs disease monitoring and diagnostic performance, applied to tau PET</article-title>
      <source>Alzheimer‚Äôs &amp; Dementia</source>
      <publisher-name>Wiley Online Library</publisher-name>
      <year iso-8601-date="2022">2022</year>
      <volume>18</volume>
      <pub-id pub-id-type="doi">10.1002/alz.063177</pub-id>
      <fpage>e063177</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-scrucca2016some">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Scrucca</surname><given-names>Luca</given-names></name>
      </person-group>
      <article-title>On some extensions to GA package: Hybrid optimisation, parallelisation and islands evolution</article-title>
      <source>arXiv preprint arXiv:1605.01931</source>
      <year iso-8601-date="2016">2016</year>
      <pub-id pub-id-type="doi">10.48550/arXiv.1605.01931</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-lme4">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Bates</surname><given-names>Douglas</given-names></name>
        <name><surname>M√§chler</surname><given-names>Martin</given-names></name>
        <name><surname>Bolker</surname><given-names>Ben</given-names></name>
        <name><surname>Walker</surname><given-names>Steve</given-names></name>
      </person-group>
      <article-title>Fitting linear mixed-effects models using lme4</article-title>
      <source>Journal of Statistical Software</source>
      <year iso-8601-date="2015">2015</year>
      <volume>67</volume>
      <issue>1</issue>
      <pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id>
      <fpage>1</fpage>
      <lpage>48</lpage>
    </element-citation>
  </ref>
  <ref id="ref-longpower">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Iddi</surname><given-names>Samuel</given-names></name>
        <name><surname>Donohue</surname><given-names>Michael C.</given-names></name>
      </person-group>
      <article-title>Power and sample size for longitudinal models in r-the longpower package and shiny app</article-title>
      <source>R Journal</source>
      <publisher-name>R Foundation for Statistical Computing</publisher-name>
      <year iso-8601-date="2022">2022</year>
      <volume>14</volume>
      <issue>1</issue>
      <pub-id pub-id-type="doi">10.32614/RJ-2022-022</pub-id>
      <fpage>264</fpage>
      <lpage>281</lpage>
    </element-citation>
  </ref>
  <ref id="ref-llorente2026enhanced">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Llorente-Saguer</surname><given-names>Isaac</given-names></name>
        <name><surname>Oxtoby</surname><given-names>Neil P</given-names></name>
      </person-group>
      <article-title>Enhanced monitoring of alzheimer‚Äôs disease brain atrophy using composite value ratios of volumes</article-title>
      <source>Brain Communications</source>
      <publisher-name>Oxford University Press UK</publisher-name>
      <year iso-8601-date="2026">2026</year>
      <volume>8</volume>
      <issue>1</issue>
      <pub-id pub-id-type="doi">10.1093/braincomms/fcaf497</pub-id>
      <fpage>fcaf497</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-llorente2025theta">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Llorente-Saguer</surname><given-names>Isaac</given-names></name>
        <name><surname>Arber</surname><given-names>Charles</given-names></name>
        <name><surname>Oxtoby</surname><given-names>Neil P</given-names></name>
      </person-group>
      <article-title>Theta, a multidimensional ratio biomarker applied to five amyloid beta peptides for investigations in familial alzheimer‚Äôs disease</article-title>
      <source>medRxiv</source>
      <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
      <year iso-8601-date="2025">2025</year>
      <pub-id pub-id-type="doi">10.1101/2025.08.06.25333131</pub-id>
      <fpage>2025</fpage>
      <lpage>08</lpage>
    </element-citation>
  </ref>
</ref-list>
</back>
</article>
